Efficacious cefazolin prophylactic dose for morbidly obese women undergoing bariatric surgery based on evidence from subcutaneous microdialysis and populational …

EC Palma, NG Meinhardt, AT Stein, I Heineck… - Pharmaceutical …, 2018 - Springer
Purpose To determine the efficacious cefazolin prophylactic dose for bariatric surgery using
free subcutaneous concentrations accessed by microdialysis after 2 g or 3 g iv bolus dosing …

Peri-operative medication dosing in adult obese elective surgical patients: a systematic review of clinical studies

Z Hussain, C Curtain, C Mirkazemi, STR Zaidi - Clinical drug investigation, 2018 - Springer
Background Despite the increasing numbers of obese patients undergoing elective surgery,
there is a lack of evidence-based dosing guidelines for peri-operative medications in …

Penetration of Antibiotics into Subcutaneous and Intramuscular Interstitial Fluid: A Meta-Analysis of Microdialysis Studies in Adults

PJ De Sutter, E Hermans, P De Cock… - Clinical …, 2024 - Springer
Abstract Background and Objective The interstitial fluid of tissues is the effect site for
antibiotics targeting extracellular pathogens. Microdialysis studies investigating these …

Prophylactic cefazolin concentrations in morbidly obese patients undergoing sleeve gastrectomy: do we achieve targets?

M Grégoire, R Dumont, L Ronchi, JB Woillard… - International journal of …, 2018 - Elsevier
Morbid obesity is known to increase the risk of surgical site infections. Optimal
concentrations of prophylactic antibacterial drugs are required. Using Monte Carlo …

[HTML][HTML] Cefazolin tissue concentrations with a prophylactic dose administered before sleeve gastrectomy in obese patients: a single centre study in 116 patients

R Cinotti, R Dumont, L Ronchi, A Roquilly… - British Journal of …, 2018 - Elsevier
Background In obese patients undergoing sleeve gastrectomy, the blood and fatty-tissue
concentrations of cefazolin required for adequate antibiotic prophylaxis are uncertain …

[HTML][HTML] Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to …

KP van Rhee, CAJ Knibbe, PD van der Linden… - Clinical …, 2024 - Springer
Individuals with obesity are at increased risk of developing infectious diseases. Timely
administration of an effective dose of an antimicrobial agent is paramount to safeguard …

[HTML][HTML] Local tissue concentrations of cefazolin during total joint arthroplasty: a systematic review

M Mannarino, J Montreuil, M Tanzer… - Canadian Journal of …, 2023 - ncbi.nlm.nih.gov
Background: Periprosthetic joint infections (PJI) following joint arthroplasty are now the
leading cause of reoperation and are associated with serious morbidity to the patient, often …

Model‐Informed Approaches to Support Drug Development for Patients With Obesity: A Regulatory Perspective

X Pan, L Wang, J Liu, JC Earp, Y Yang… - The Journal of …, 2023 - Wiley Online Library
Obesity, which is defined as having a body mass index of 30 kg/m2 or greater, has been
recognized as a serious health problem that increases the risk of many comorbidities (eg …

Utility of microdialysis in infectious disease drug development and dose optimization

AN Deitchman, MT Heinrichs, V Khaowroongrueng… - The AAPS journal, 2017 - Springer
Adequate drug penetration to a site of infection is absolutely imperative to ensure sufficient
antimicrobial treatment. Microdialysis is a minimally invasive, versatile technique, which can …

[HTML][HTML] Evaluation of total body weight and body mass index cut-offs for increased cefazolin dose for surgical prophylaxis

M Hites, G Deprez, F Wolff, B Ickx, A Verleije… - International journal of …, 2016 - Elsevier
French and American guidelines recommend increased dosage regimens of cefazolin (CFZ)
for surgical prophylaxis in patients with a body mass index (BMI)≥ 35 kg/m 2 or with a total …